(Q36001323)

11 August 2017

1 reference

title

Pituitary pars intermedia dysfunction: equine Cushing's disease (English)

1 reference

pituitary pars intermedia dysfunction

11 August 2017

main subject

0 references

1 reference

Harold C Schott

1

1 reference

11 August 2017

publication date

1 August 2002

1 reference

Veterinary Clinics of North America: Equine Practice

11 August 2017

published in

1 reference

11 August 2017

volume

18

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

237-270

1 reference

Immunocytochemical demonstration of proopiomelanocortin-derived peptides in pituitary adenomas of the pars intermedia in horses

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Effect of age on immunocytochemical staining characteristics of adenohypophyseal cells in Mongolian pony mares and stallions

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Dynamics of the regulation of the hypothalamo-pituitary-adrenal (HPA) axis determined using a nonsurgical method for collecting pituitary venous blood from horses

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Effect of insulin-induced hypoglycaemia on secretion patterns and rates of corticotrophin-releasing hormone, arginine vasopressin and adrenocorticotrophin in horses

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Dopamine D2 receptor plays a critical role in cell proliferation and proopiomelanocortin expression in the pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Heterogeneity in POMC expression among explanted melanotropes decreases with time in culture and bromocriptine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Proopiolipomelanocortin Peptides in Normal Pituitary, Pituitary Tumor, and Plasma of Normal and Cushing's Horses*

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Equine Cushing's disease: differential regulation of beta-endorphin processing in tumors of the intermediate pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Adrenocortical function in the horse

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Diurnal and episodic variations of plasma hydrocortisone concentrations in horses

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Factors affecting the circadian rhythm in plasma cortisol concentrations in the horse

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

The effect of social stress on adrenal axis activity in horses: the importance of monitoring corticosteroid-binding globulin capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Equine pituitary adenoma: a functional and morphological study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Pituitary-independent Cushing's syndrome in a horse.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Bioactive and Immunoreactive Adrenocorticotropin in Normal Equine Pituitary and in Pituitary Tumors of Horses with Cushing's Disease*

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Equine Cushing's disease: plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Pars intermedia of the hypophysis of rats after early-postnatal lesions of the basal hypothalamus: quantitative and qualitative observations

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Equine Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Glucose metabolism in a pony mare with a tumour of the pituitary gland pars intermedia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Cushing's syndrome in a horse

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

A Case of Pituitary Adrenocorticotropin-Dependent Cushing's Syndrome in the Horse*

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

A case of a pony with Cushing's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Diabetes Mellitus in the Horse: a Case Report and Review of the Literature

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Pharmacokinetics and metabolic effects of triamcinolone acetonide and their possible relationships to glucocorticoid-induced laminitis in horses.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Plasma adrenocorticotropin concentration in healthy horses and in horses with clinical signs of hyperadrenocorticism

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Hyperlipemia in 9 miniature horses and miniature donkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

The effect of starting time on dexamethasone suppression test results in horses

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Plasma ACTH and Cortisol Responses to TRF, Vasopressin or Hypoglycemia in Cushing's Disease and Nelson′s Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Plasma Cortisol Response to Thyrotropin-Releasing Hormone and Luteinizing Hormone-Releasing Hormone in Cushing's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Laboratory diagnosis of equine pituitary pars intermedia adenoma

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Validation of nonradioactive chemiluminescent immunoassay methods for the analysis of thyroxine and cortisol in blood samples obtained from dogs, cats, and horses

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Measurement of basal serum insulin concentration in the diagnosis of Cushing's disease in ponies

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Evidence that the insulin secretagogue, β-cell-tropin, is ACTH22–39

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Urinary concentration of corticoids in normal horses and horses with hyperadrenocorticism

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Salivary and plasma concentration of cortisol in normal horses and horses with Cushing's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Pituitary disorders. Drug treatment options

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Transsphenoidal hypophysectomy in beagle dogs: evaluation of a microsurgical technique

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Pergolide treatment for Cushing's syndrome in a horse

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Control of Bioactive Corticotropin Release from the Neuro-Intermediate Lobe of the Rat Pituitaryin Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Differential effect of trilostane on the progestin milieu in the pregnant mare.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Therapy of Cushing's syndrome with steroid biosynthesis inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Cushing's disease: a new approach to therapy in equine and canine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Toward practical prevention of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

Influence of chromium tripicolinate on growth and glucose metabolism in yearling horses.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

From macroprolactinoma to concomitant ACTH-PRL hypersecretion with Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0739%2802%2900018-4

7 January 2021

10.1016/S0749-0739(02)00018-4

Identifiers

DOI

1 reference

11 August 2017

1 reference